Illumina Q4 core revenue up 1% to $1.1B; FY2025 guided to low single-digit growth

ILLUMINA, INC.

2024-FY EPS reported -$7.69 revenue$4,372,000,000

Core Illumina Q4 revenue $1.104B (+1% YoY); GAAP EPS $0.73, non-GAAP EPS $0.95.
Full year core revenue $4.332B (-2% YoY); free cash flow $1.07B.
FY2025 guidance: core revenue $4.28B-$4.4B; non-GAAP Op margin ~23%; non-GAAP EPS $4.50-$4.65.
China Ministry of Commerce impact excluded from guidance; company notes current macro/political environment.
Key partnerships announced: NVIDIA, UK Biobank proteomics, Regeneron/Truveta Genome Project.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.